Ascentage Pharma Group International vs ADC Therapeutics SA
Ascentage Pharma Group International and ADC Therapeutics SA are similar in size: $79.9m and $81.4m of revenue in their latest fiscal years. ADC Therapeutics SA grew faster (14.9% against -41.4%). ADC Therapeutics SA kept more of each dollar of sales as profit: a net margin of -175.3% against -216.5%.
| Latest fiscal year | Ascentage Pharma Group InternationalAAPG, 2025 | ADC Therapeutics SAADCT, 2025 |
|---|---|---|
| Revenue | $79.9m | $81.4m |
| Revenue growth | -41.4% | 14.9% |
| Net income | −$173m | −$143m |
| Operating margin | — | -149.3% |
| Net margin | -216.5% | -175.3% |
| Return on equity | -153.3% | — |
| Free cash flow | −$167m | −$141m |
| Cash | $171m | $261m |
| Total debt | $284m | $116m |
| Debt to equity | 150.1% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $1.3m | — |
| Employees | — | 188 |
| Market value | $1.26bn | $198m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 6 sales |